Johns Hopkins Malaria Minute

By: Johns Hopkins Bloomberg School of Public Health
  • Summary

  • Impactful malaria science, and the trailblazers leading the fight. A podcast from the Johns Hopkins Malaria Research Institute.
    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2
Episodes
  • EXTENDED: First Reference Genome Sequence of P. vivax from Ethiopia (with Jane Carlton, Delenasaw Yewhalaw, and Francisco Callejas Hernandez)
    Oct 29 2024

    Today, how DNA from a single patient in Ethiopia can shed light on the big picture of malaria.

    • Why is Plasmodium vivax significant in malaria research, especially in Ethiopia?
    • How does genomic sequencing contribute to understanding and controlling malaria?
    • How are advances in sequencing technology influencing malaria research?

    With Jane Carlton, Delenasaw Yewhalaw, and Francisco Callejas Hernandez

    About The Podcast

    The Johns Hopkins Malaria Minute is produced by the Johns Hopkins Malaria Research Institute to highlight impactful malaria research and to share it with the global community.

    Show more Show less
    9 mins
  • How Comparative Genomics Can Help Find the Best Treatments for Malaria
    Oct 15 2024

    'Comparative genomics' helps identify genes that can serve as targets for future drugs and vaccines.

    Transcript

    Not all parasites are alike. Genetic mutations mean that malaria parasites evolve differently in different regions – and even within the same region. One species thought to be particularly genetically diverse is Plasmodium vivax. It’s the second most common species of malaria, found in South East Asia, South America, and some parts of Africa. In Ethiopia, 20% of malaria cases are thought to be caused by P. vivax. In a new paper, scientists made a ‘reference genome’ from a sample of P. vivax in Ethiopia. They collected blood from an infected patient, extracted the DNA, and ‘read’ its fragments to form the parasite genome. This allows scientists to compare P. vivax samples across regions – and understand their similarities and differences. Importantly, this study of ‘comparative genomics’ ie comparing genomes will help identify the genes that stay the same – the conserved genes – and those which are different - the unique genes -which could serve as targets for future drugs and vaccines.

    Source

    Assembled genome of an Ethiopian Plasmodium vivax isolate generated using GridION long-read technology

    About The Podcast

    The Johns Hopkins Malaria Minute podcast is produced by the Johns Hopkins Malaria Research Institute to highlight impactful malaria research and to share it with the global community.

    Show more Show less
    1 min
  • EXTENDED: The Surprising Advantage of Transmission-Blocking Vaccines (with Ilinca Ciubotariu, Qixin He and Giovanna Carpi)
    Oct 1 2024

    The World Health Organisation has recommended two licenced malaria vaccines. Those vaccines have been a long time coming - but are they the best?

    In this extended episode of the Johns Hopkins Malaria Minute, we ask:

    • Why is developing a malaria vaccine so challenging?
    • How does antigen variation play affect the effectiveness of malaria vaccines?
    • What are transmission-blocking vaccines (TBVs), and why haven't they gained much interest despite their potential?

    With Ilinca Ciubotariu, Qixin He and Giovanna Carpi.

    About The Podcast

    The Johns Hopkins Malaria Minute is produced by the Johns Hopkins Malaria Research Institute to highlight impactful malaria research and to share it with the global community.

    Show more Show less
    9 mins

What listeners say about Johns Hopkins Malaria Minute

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.